According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$4.44 M. an increase over its 2022 earnings that were of -$6.48 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$4.44 M | -31.5% |
2022 | -$6.48 M | 16.86% |
2021 | -$5.55 M | 194.32% |
2020 | -$1.89 M | -58.76% |
2019 | -$4.57 M | -65.66% |
2018 | -$13.31 M | 4.84% |
2017 | -$12.69 M | -2.17% |
2016 | -$12.98 M | 32.12% |
2015 | -$9.82 M | -307.74% |
2014 | $4.72 M | -197.5% |
2013 | -$4.85 M | |
2010 | -$7.58 M | -14.02% |
2009 | -$8.81 M | -57.28% |
2008 | -$20.62 M | -8.03% |
2007 | -$22.42 M | 3.85% |
2006 | -$21.59 M | 39.31% |
2005 | -$15.5 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | 4,052.26% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.95 M | 326.85% | ๐บ๐ธ USA |